Hr+, her2-, advanced breast cancer Clinical Trials

Delta Trials records 10 clinical trials for Hr+, her2-, advanced breast cancer in its publicly accessible dataset. From the full dataset, 4 actively seeking eligible participants and 0 trials have reached completion. This research is conducted across 50 study locations around the world. An additional 6 trials are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.